Evidence map›Paper›PMID 40810962›Full record

ArticleJournal of neurology2025

Impact of expanded Thrombolysis in Cerebral Infarction (eTICI) grades on clinical outcomes in patients with large ischemic strokes receiving endovascular treatment.

Miao Chai, Qin Wan, Linyu Li, Wei Chen, Haoxuan Zhu, Jifei Liu, Jie Yang, Guojian Liu, Changwei Guo, Jinfu Ma and 9 more

Abstract readMulticenter Study
PubMed Publisher
In one paragraph

Article in Journal of neurology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

19 authors.

Miao Chai *Department of Neurology, Lanzhou University Second Hospital, Cuiyingmen No.82, Chengguan District, Lanzhou, 730030, China.
Qin Wan *Department of Neurology, The 908th Hospital of Chinese People's Liberation Army Joint Logistic Support Force, Nanchang, China.
Linyu Li *Department of Neurology, Xinqiao Hospital and The Second Affiliated Hospital, Army Medical University (Third Military Medical University), No. 183 Xinqiao Main Street, Shapingba District, Chongqing, 400037, China.
Wei Chen *Department of Neurology, Lanzhou University Second Hospital, Cuiyingmen No.82, Chengguan District, Lanzhou, 730030, China.
Haoxuan ZhuDepartment of Neurology, The 908th Hospital of Chinese People's Liberation Army Joint Logistic Support Force, Nanchang, China.
Jifei LiuDepartment of Neurology, Lanzhou University Second Hospital, Cuiyingmen No.82, Chengguan District, Lanzhou, 730030, China.
Jie YangDepartment of Neurology, Xinqiao Hospital and The Second Affiliated Hospital, Army Medical University (Third Military Medical University), No. 183 Xinqiao Main Street, Shapingba District, Chongqing, 400037, China.
Guojian LiuDepartment of Neurology, Xinqiao Hospital and The Second Affiliated Hospital, Army Medical University (Third Military Medical University), No. 183 Xinqiao Main Street, Shapingba District, Chongqing, 400037, China.
Changwei GuoDepartment of Neurology, Xinqiao Hospital and The Second Affiliated Hospital, Army Medical University (Third Military Medical University), No. 183 Xinqiao Main Street, Shapingba District, Chongqing, 400037, China.
Jinfu MaDepartment of Neurology, Xinqiao Hospital and The Second Affiliated Hospital, Army Medical University (Third Military Medical University), No. 183 Xinqiao Main Street, Shapingba District, Chongqing, 400037, China.
Dahong YangDepartment of Neurology, Xinqiao Hospital and The Second Affiliated Hospital, Army Medical University (Third Military Medical University), No. 183 Xinqiao Main Street, Shapingba District, Chongqing, 400037, China.
Zhenxuan TianDepartment of Neurology, The Second Affiliated Hospital of Chongqing Medical University, Chongqing, China.
Boyu ChenDepartment of Neurology, The Second Affiliated Hospital of Chongqing Medical University, Chongqing, China.
Chawen DingDepartment of Neurology, The Second Affiliated Hospital of Chongqing Medical University, Chongqing, China.
Xiaolei ShiDepartment of Neurology, Xinqiao Hospital and The Second Affiliated Hospital, Army Medical University (Third Military Medical University), No. 183 Xinqiao Main Street, Shapingba District, Chongqing, 400037, China.
Shihai YangDepartment of Neurology, Xinqiao Hospital and The Second Affiliated Hospital, Army Medical University (Third Military Medical University), No. 183 Xinqiao Main Street, Shapingba District, Chongqing, 400037, China.
Jiaxing SongDepartment of Neurology, Xinqiao Hospital and The Second Affiliated Hospital, Army Medical University (Third Military Medical University), No. 183 Xinqiao Main Street, Shapingba District, Chongqing, 400037, China.
Zhuang Li *Department of Neurology, Xinqiao Hospital and The Second Affiliated Hospital, Army Medical University (Third Military Medical University), No. 183 Xinqiao Main Street, Shapingba District, Chongqing, 400037, China. zhuangli_tmmu@163.com.
Zhenchang Zhang *Department of Neurology, Lanzhou University Second Hospital, Cuiyingmen No.82, Chengguan District, Lanzhou, 730030, China. tougao13893647595@163.com.ORCID http://orcid.org/0000-0002-1246-3745

Funding

Clinical advantage specialty construction project of Gansu Province 2024Cuiying Scientific and Technological Innovation Program of The Second Hospital & Clinical Medical School, Lanzhou University CY2023-QN-B16Major Project of Science and Technology Innovation in Health Industry of Gansu Province GSWSZD2024-15Medical Innovation and Development Project of Lanzhou University lzuyxcx-2022-107Medical Innovation and Development Project of Lanzhou University lzuyxcx-2022-195Natural Science Foundation of Chongqing NO. CSTB2023NSCQ-MSX0604Noncommunicable Chronic Diseases-National Science and Technology Major Project 2024ZD0527800Science and Health Joint Medical Research Project of Chongqing NO. 2025QNXM012
6 · The paper itself

Abstract

objectiveThis study aimed to investigate the impact of the expanded Thrombolysis in Cerebral Infarction (eTICI) grades on clinical outcomes after endovascular treatment (EVT) for large ischemic strokes.

methodsThis study was a substudy of a prospective nationwide multicenter registry that included 490 patients with large ischemic strokes undergoing EVT. The primary outcome was a 90-day modified Rankin Scale (mRS) score of 0-3. Secondary outcomes included the distribution of mRS score, and mRS scores of 0-2 and 0-4 at 90 days. Safety outcomes included 90-day mortality and symptomatic intracranial hemorrhage (sICH) within 48 h.

resultsAmong 490 patients treated with EVT, 67 (13.7%), 125 (25.5%), and 298 (60.8%) achieved eTICI grades 0-2a, 2b, and 2c-3, respectively. Compared with eTICI grades 0-2a, eTICI grade 2b showed no significant association with an mRS score of 0-3, while eTICI grades 2c-3 were significantly associated with higher odds of achieving an mRS score of 0-3 (adjusted odds ratios [aOR] 3.04, 95% CI 1.39-6.62). Mortality was lower for eTICI grades 2c-3 than for grades 0-2a (aOR 0.47, 95% CI 0.25-0.89). There were no significant differences in sICH rates among three groups. The predicted probability of an mRS score of 0-3 progressively decreased with increasing procedure time, while the predicted probability of mortality progressively increased.

conclusionIn patients with large ischemic strokes undergoing EVT, eTICI grades 2c-3 were significantly associated with improved clinical outcomes. This study suggests that eTICI grades 2c-3 should be considered the ideal target for successful reperfusion in this patient population.

Indexed as

Endovascular ProceduresIschemic StrokeOutcome Assessment, Health CareThrombolytic TherapyAgedAged, 80 and overFemaleHumansMaleMiddle AgedProspective StudiesRegistriesSeverity of Illness IndexTreatment OutcomeAcute ischemic strokeClinical outcomesEndovascular treatmentExpanded Thrombolysis in Cerebral InfarctionLarge ischemic strokes

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.